Form 4: FIREFLY NEUROSCIENCE CEO Boosts Stake

Gregory Lipschitz, CEO and Director of FIREFLY NEUROSCIENCE, INC., increased his beneficial ownership by 65,988 shares through RSU vesting.

Summary

• Gregory Lipschitz, the Chief Executive Officer and Director of FIREFLY NEUROSCIENCE, INC. (AIFF), reported a change in his beneficial ownership of the company's common stock.
• On March 10, 2026, Mr. Lipschitz acquired 65,988 shares of common stock due to the vesting of restricted stock units (RSUs).
• These RSUs were part of a grant made on April 18, 2025, under the Issuer's 2024 Long-Term Incentive Plan.
• The vesting occurred after the Compensation Committee of the board of directors determined that the performance conditions for these specific shares had been met.
• The shares were acquired at a price of $0.00, which is typical for RSU vesting.
• Following this transaction, Mr. Lipschitz directly owns 65,988 shares of Common Stock.
• Additionally, he indirectly owns 464,196 shares through Bower Four Capital Corporation, where he is the sole stockholder, bringing his total beneficial ownership to 530,184 shares.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive event. The vesting of performance-based RSUs indicates the company met specific targets, and the increased insider ownership enhances alignment between management and shareholders.

Positives

• The vesting of 65,988 restricted stock units indicates that specific performance conditions set by the Compensation Committee were successfully met.
• Increased direct beneficial ownership by the CEO enhances alignment between management's interests and those of the shareholders.

Future Outlook

NA

Management Comments

• The Compensation Committee of the board of directors of the Issuer determined that the performance conditions had been met for the vesting of 65,988 of these shares.

Industry Context

StockSavvy.ai notes that RSU vesting is a standard component of executive compensation packages, designed to align management incentives with long-term shareholder value creation. The fulfillment of performance conditions for vesting suggests the company is meeting internal operational or financial targets, which can be a positive signal for investors.

Comparison to Industry Standards

• RSU vesting, particularly when tied to performance conditions, is a common practice across various industries, including biotechnology and healthcare technology, where companies like Moderna (MRNA) or Intuitive Surgical (ISRG) utilize similar long-term incentive plans to retain and motivate key executives.
• The $0.00 acquisition price is standard for vested RSUs, reflecting the compensation nature of the grant rather than a market purchase.

Related Party Transactions

• Gregory Lipschitz indirectly owns 464,196 shares through Bower Four Capital Corporation, of which he is the sole stockholder. He disclaims beneficial ownership except to the extent of his pecuniary interest.

Stakeholder Impact

• Shareholders benefit from increased alignment of interests with the CEO due to higher insider ownership.
• The successful vesting of performance-based compensation may indicate positive operational performance, potentially benefiting employees and future strategic initiatives.

Key Dates

Recommendation

While the vesting of restricted stock units is a positive indicator of met performance targets and increased insider alignment, it does not represent an open-market purchase. This Form 4 provides a snapshot of executive compensation and ownership structure, which is generally a 'hold' signal unless combined with other significant financial or strategic news.

Keywords

FIREFLY NEUROSCIENCE, AIFF, Gregory Lipschitz, Form 4, insider transaction, restricted stock units, RSU vesting, CEO, Director, beneficial ownership, corporate governance